11d
GlobalData on MSNBeckley Psytech completes subjects’ enrolment for Phase IIb trial of TRD therapyBeckley Psytech has completed subject enrolment for the core stage of the global Phase IIb clinical trial of patent-protected ...
6d
GlobalData on MSNTrevi’s Phase IIb chronic cough success spikes stock by 71%The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...
VanLanschot Kempen Life Sciences Conference MADRID, Spain and CAMBRIDGE, Mass., March 14, 2025 (GLOBE NEWSWIRE) -- Oryzon ...
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
Additional finalized Phase IIa clinical trials with vafidemstat include the ETHERAL ... randomized, double blind Phase IIb PORTICO trial (final data presented at ECNP-2024). Following receipt of the ...
Oryzon Genomics, S.A.: ORYZON to Provide Corporate Progress Updates at Several Events in March-April
Van Lanschot Kempen Life Sciences Conference MADRID, Spain and CAMBRIDGE, Mass., March 14, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage ...
GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB , a company discovering and developing novel ...
The Phase Ib and Phase IIa studies showed a good safety and tolerability ... effect compared with current treatment options. A Phase IIb study, completed in 2023, showed that mesdopetam has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results